Company Name: |
GLP Pharma Standards
|
Tel: |
+91 9866074638 |
Email: |
info@glppharmastandards.com |
Products Intro: |
Product Name:Atorvastatin EP Impurity-E CAS:1428118-38-0 Purity:98% Package:50 MG; 100 MG; 250 MG ; 500 mg
|
Company Name: |
Hefei fuya biotechnology co. LTD
|
Tel: |
18096409024 |
Email: |
sales02@foreversyn.com |
Products Intro: |
Product Name:Atorvastatin impurity 32/(3S,5S)-Atorvastatin Sodium Salt/Atorvastatin EP Impurity E Sodium Salt/(3S,5S)-Atorvastatin Calcium Salt/((3S,5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate) Sodium Salt CAS:1428118-38-0 Purity:95% Package:25mg;100mg;250mg;500mg(按需分装)
|
Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
Tel: |
18818260767 |
Email: |
sales@chemegen.com |
Products Intro: |
Product Name:(3S,5S)-Atorvastatin sodium salt CAS:1428118-38-0 Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
|
| (3S,5S)-Atorvastatin (sodium salt) Basic information |
Product Name: | (3S,5S)-Atorvastatin (sodium salt) | Synonyms: | Atorvastatin impurity 32/(3S,5S)-Atorvastatin Sodium Salt/Atorvastatin EP Impurity E Sodium Salt/(3S,5S)-Atorvastatin Calcium Salt/((3S,5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate) Sodium Sal;Atorvastatin impurity 32/(3S,5S)-Atorvastatin Sodium Salt/Atorvastatin EP Impurity E Sodium Salt/(3S,5S)-Atorvastatin Calcium Salt/((3S,5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate) Sodium Salt;Atorvastatin EP Impurity E Sodium Salt | CAS: | 1428118-38-0 | MF: | C33H36FN2NaO5 | MW: | 582.65 | EINECS: | | Product Categories: | | Mol File: | 1428118-38-0.mol | |
| (3S,5S)-Atorvastatin (sodium salt) Chemical Properties |
storage temp. | Store at -20°C | solubility | ≤0.5mg/ml in ethanol;15mg/ml in DMSO;25mg/ml in dimethyl formamide | form | crystalline solid | Stability: | Hygroscopic |
| (3S,5S)-Atorvastatin (sodium salt) Usage And Synthesis |
Uses | (3S,5S)-Atorvastatin Sodium Salt (Atorvastatin EP Impurity E) is a selective, competitive HMG-CoA reductase inhibitor. The only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia. | Biological Activity | atorvastatin exists in four optical forms. the (3r, 5r)-atorvastatin enantiomer displays the greatest activity against hmg-coa reductase. (3s,5s)-atorvastatin is an enantiomer of atorvastatin with little or no inhibitory activity against hmg-coa reductase [1]. atorvastatin is a synthetic hmg-coa reductase inhibitor implicated in lowering plasma cholesterol levels by inhibiting endogenous cholesterol synthesis. atorvastatin also reduces triglyceride levels through an as yet unproven mechanism [2]. in various trials in patients with hypercholesterolaemia, atorvastatin produced greater reductions in total cholesterol, apolipoprotein b, ldl-cholesterol and triglyceride levels. in patients with primary hypercholesterolaemia, atorvastatin in combination with colestipol produced significant reductions in ldl-cholesterol levels and smaller reductions in triglyceride levels than atorvastatin monotherapy [2]. | references | [1] kocarek t a, dahn m s, cai h, et al. regulation of cyp2b6 and cyp3a expression by hydroxymethylglutaryl coenzyme a inhibitors in primary cultured human hepatocytes[j]. drug metabolism and disposition, 2002, 30(12): 1400-1405. [2] lea a p, mctavish d. atorvastatin[j]. drugs, 1997, 53(5): 828-847. |
| (3S,5S)-Atorvastatin (sodium salt) Preparation Products And Raw materials |
|